zimlovisertib (PF-06650833) / Pfizer  >>  Phase 1
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
zimlovisertib (PF-06650833) / Pfizer
NCT02224651: Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions

Completed
1
40
US
PF-06650833, Placebo
Pfizer
Healthy
06/15
06/15
NCT02609139: Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects

Completed
1
18
US
PF-06650833
Pfizer
Healthy
02/16
02/16
NCT02485769: Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects

Completed
1
71
US
PF-06650833, Placebo
Pfizer
Healthy
04/16
04/16
NCT02936154: Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects

Completed
1
10
Japan
PF-06650833, placebo
Pfizer
Healthy
10/16
10/16
NCT03308110: Bioavailability and Food Effect Study of Two Formulations of PF-06650833

Completed
1
24
Europe
PF-06650833
Pfizer
Healthy
12/17
01/18
NCT03827668: A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTS

Completed
1
15
US
PF-06650833 alone, PF-06651600 alone, PF-06650833 together with PF-06651600
Pfizer
Healthy
04/19
04/19
NCT05064332: A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)

Completed
1
10
US
PF-06650833, Ethinyl estradiol (EE) and levonogestrel (LN), Oral contraceptive (OC)
Pfizer
Healthy
12/21
12/21

Download Options